NIM
NEOS Investment Management Portfolio holdings
AUM
$8.08B
This Quarter Return
+4.83%
1 Year Return
+24.46%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$4.25B
AUM Growth
+$4.25B
(+28%)
Cap. Flow
+$886M
Cap. Flow
% of AUM
20.88%
Top 10 Holdings %
Top 10 Hldgs %
37.69%
Holding
613
New
34
Increased
490
Reduced
55
Closed
25
Top Buys
| 1 |
Vanguard Russell 2000 ETF
VTWO
|
$76.3M |
| 2 |
Apple
AAPL
|
$70.6M |
| 3 |
NVIDIA
NVDA
|
$54.5M |
| 4 |
Microsoft
MSFT
|
$53.4M |
| 5 |
Amazon
AMZN
|
$39.8M |
Top Sells
| 1 |
SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
|
$17.1M |
| 2 |
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
|
$17.1M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
$3.06M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$2.53M |
| 5 |
Insulet
PODD
|
$1.32M |
Sector Composition
| 1 | Technology | 33.68% |
| 2 | Consumer Discretionary | 10.52% |
| 3 | Healthcare | 10.01% |
| 4 | Communication Services | 9.79% |
| 5 | Financials | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Hasbro
HAS
$11.4B
| $325K | 0.01% |
5,808
+1,240
| +27% | +$69.3K |
|
552
Donaldson
DCI
$9.28B
| $324K | 0.01% |
+4,818
| New | +$324K |
|
553
Franklin Resources
BEN
$13.3B
| $323K | 0.01% |
15,895
+3,731
| +31% | +$75.7K |
|
554
Teledyne Technologies
TDY
$25.2B
| $303K | 0.01% |
652
-4
| -0.6% | -$1.86K |
|
555
NuScale Power
SMR
$4.64B
| $297K | 0.01% |
+16,560
| New | +$297K |
|
556
Ulta Beauty
ULTA
$22.1B
| $296K | 0.01% |
681
-5
| -0.7% | -$2.18K |
|
|
ITCI
557
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $283K | 0.01% |
3,388
| – | – |
|
558
Janux Therapeutics
JANX
$1.37B
| $280K | 0.01% |
5,223
-8,053
| -61% | -$431K |
|
|
PARA
559
DELISTED
Paramount Global Class B
PARA
| $280K | 0.01% |
26,730
+6,217
| +30% | +$65K |
|
560
Zebra Technologies
ZBRA
$16.1B
| $273K | 0.01% |
707
-5
| -0.7% | -$1.93K |
|
561
Fox Class B
FOX
$24.3B
| $267K | 0.01% |
+5,827
| New | +$267K |
|
562
Relay Therapeutics
RLAY
$619M
| $266K | 0.01% |
64,655
+6,365
| +11% | +$26.2K |
|
563
Brookfield Renewable
BEP
$7.2B
| $265K | 0.01% |
+11,640
| New | +$265K |
|
564
Argan
AGX
$3.11B
| $263K | 0.01% |
+1,920
| New | +$263K |
|
565
Factset
FDS
$14.1B
| $253K | 0.01% |
526
-4
| -0.8% | -$1.92K |
|
566
Campbell Soup
CPB
$9.52B
| $252K | 0.01% |
6,076
+1,238
| +26% | +$51.4K |
|
567
Essex Property Trust
ESS
$17.4B
| $251K | 0.01% |
888
-6
| -0.7% | -$1.7K |
|
568
Snap-on
SNA
$17B
| $248K | 0.01% |
731
-5
| -0.7% | -$1.7K |
|
569
Brown-Forman Class B
BF.B
$14.2B
| $243K | 0.01% |
6,405
+1,238
| +24% | +$47K |
|
570
Xenon Pharmaceuticals
XENE
$2.98B
| $240K | 0.01% |
+6,111
| New | +$240K |
|
571
CG Oncology
CGON
$2.04B
| $239K | 0.01% |
8,329
+817
| +11% | +$23.4K |
|
572
Catalyst Pharmaceutical
CPRX
$2.52B
| $237K | 0.01% |
11,352
| – | – |
|
573
Sarepta Therapeutics
SRPT
$1.78B
| $236K | 0.01% |
1,943
+237
| +14% | +$28.8K |
|
574
Molina Healthcare
MOH
$9.8B
| $234K | 0.01% |
803
-6
| -0.7% | -$1.75K |
|
575
Arvinas
ARVN
$568M
| $227K | 0.01% |
11,835
-4,915
| -29% | -$94.2K |
|